C H M Jamieson

Summary

Affiliation: University of California
Country: USA

Publications

  1. doi request reprint Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
    Catriona Jamieson
    Moores UC San Diego Cancer Centre, 3855 Health Sciences Drive, La Jolla, CA, 92093 0820, USA
    J Transl Med 13:294. 2015
  2. pmc NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches
    Wenxue Ma
    Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America
    PLoS ONE 7:e39725. 2012
  3. pmc A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions
    Omer Raheem
    Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
    J Transl Med 9:185. 2011
  4. pmc Chronic myeloid leukemia stem cell biology
    Leslie A Crews
    Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 0820, USA
    Curr Hematol Malig Rep 7:125-32. 2012
  5. doi request reprint Miscreant myeloproliferative disorder stem cells
    C H M Jamieson
    Department of Medicine, Moores UCSD Cancer Center San Diego Medical Center, University of California, La Jolla, CA 92093 0820, USA
    Leukemia 22:2011-9. 2008
  6. doi request reprint The MLLgnant consequences of reverting to an embryonic transcriptional program
    Catriona Jamieson
    Stem Cell Research Program, Division of Hematology Oncology, Moores UCSD Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA
    Cell Stem Cell 4:97-8. 2009

Collaborators

  • Jurgen Thiele
  • Leslie A Crews
  • Wenxue Ma
  • Sheldon R Morris
  • Kristen M Smith
  • Omer Raheem
  • Qingfei Jiang
  • Ida Deichaite
  • Ifat Geron
  • Angela C Court
  • Daniel J Goff
  • Dennis A Carson
  • A Thomas Look
  • Alice Y Shih
  • Alejandro Gutierrez
  • Christina C Wu
  • Ping Wei
  • Anil Sadarangani
  • Neil W Gibson
  • Kang Li
  • Nicholas A Cacalano
  • Young B Jeong
  • Tomonori Yamaguchi
  • Heather Leu
  • Anna A Kulidjian
  • Koichi Masuda
  • Christina Wu
  • Christopher J Kane
  • Daniel Goff

Detail Information

Publications6

  1. doi request reprint Effect of treatment with a JAK2-selective inhibitor, fedratinib, on bone marrow fibrosis in patients with myelofibrosis
    Catriona Jamieson
    Moores UC San Diego Cancer Centre, 3855 Health Sciences Drive, La Jolla, CA, 92093 0820, USA
    J Transl Med 13:294. 2015
    ..We conducted an exploratory analysis of sequential BMF data from two phase I studies of long-term treatment with the Janus kinase 2 (JAK2) inhibitor fedratinib in patients with myelofibrosis...
  2. pmc NOTCH1 signaling promotes human T-cell acute lymphoblastic leukemia initiating cell regeneration in supportive niches
    Wenxue Ma
    Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California San Diego, La Jolla, California, United States of America
    PLoS ONE 7:e39725. 2012
    ..However, the cell type and context specific consequences of NOTCH1 activation, its role in human LIC regeneration, and sensitivity to NOTCH1 inhibition in hematopoietic microenvironments had not been elucidated...
  3. pmc A novel patient-derived intra-femoral xenograft model of bone metastatic prostate cancer that recapitulates mixed osteolytic and osteoblastic lesions
    Omer Raheem
    Moores Cancer Center, University of California, San Diego, La Jolla, CA, USA
    J Transl Med 9:185. 2011
    ....
  4. pmc Chronic myeloid leukemia stem cell biology
    Leslie A Crews
    Department of Medicine, Stem Cell Program and Moores Cancer Center, University of California, San Diego, La Jolla, CA 92093 0820, USA
    Curr Hematol Malig Rep 7:125-32. 2012
    ....
  5. doi request reprint Miscreant myeloproliferative disorder stem cells
    C H M Jamieson
    Department of Medicine, Moores UCSD Cancer Center San Diego Medical Center, University of California, La Jolla, CA 92093 0820, USA
    Leukemia 22:2011-9. 2008
    ..Thus, combined therapies targeting aberrant molecular pathways may be required to redirect miscreant MPD stem cells...
  6. doi request reprint The MLLgnant consequences of reverting to an embryonic transcriptional program
    Catriona Jamieson
    Stem Cell Research Program, Division of Hematology Oncology, Moores UCSD Cancer Center, University of California San Diego, 3855 Health Sciences Drive, La Jolla, CA 92093, USA
    Cell Stem Cell 4:97-8. 2009
    ..2009) have demonstrated convincingly that reversion to an embryonic transcriptional program through defective MLL gene expression contributes to the generation of myeloid leukemia stem cells...